These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16906033)

  • 1. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection.
    Suárez-Alvarez B; López-Vázquez A; Díaz-Molina B; Bernardo-Rodríguez MJ; Alvarez-López R; Pascual D; Astudillo A; Martínez-Borra J; Lambert JL; González S; López-Larrea C
    Transplantation; 2006 Aug; 82(3):354-61. PubMed ID: 16906033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
    Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N
    J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome.
    Suárez-Alvarez B; López-Vázquez A; Díaz-Peña R; Díaz-Molina B; Blanco-García RM; Alvarez-López MR; López-Larrea C
    Transpl Immunol; 2006 Dec; 17(1):43-6. PubMed ID: 17157214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble major histocompatibility complex class I-related chain A protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma.
    Ma L; Li G; Su Y; He Q; Zhang C; Zhang J
    J Clin Neurosci; 2010 Feb; 17(2):241-7. PubMed ID: 20045334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism.
    Holdenrieder S; Eichhorn P; Beuers U; Samtleben W; Stieber P; Nagel D; Peterfi A; Steinle A; Salih HR
    Anticancer Res; 2007; 27(4A):2041-5. PubMed ID: 17649819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
    Waldhauer I; Steinle A
    Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection.
    Feng L; Ke N; Ye Z; Guo Y; Li S; Li Q; Li Y
    Transplant Proc; 2009 Dec; 41(10):4332-9. PubMed ID: 20005394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
    Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
    Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
    Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MICA antibodies are related to adverse outcome in heart transplant recipients.
    Kauke T; Kaczmarek I; Dick A; Schmoeckel M; Deutsch MA; Beiras-Fernandez A; Reichart B; Spannagl M
    J Heart Lung Transplant; 2009 Apr; 28(4):305-11. PubMed ID: 19332255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?
    Zhang S; Hüe S; Sène D; Penfornis A; Bresson-Hadni S; Kantelip B; Caillat-Zucman S; Vuitton DA
    J Infect Dis; 2008 May; 197(9):1341-9. PubMed ID: 18422447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.
    Salih HR; Goehlsdorf D; Steinle A
    Hum Immunol; 2006 Mar; 67(3):188-95. PubMed ID: 16698441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.
    Arreygue-Garcia NA; Daneri-Navarro A; del Toro-Arreola A; Cid-Arregui A; Gonzalez-Ramella O; Jave-Suarez LF; Aguilar-Lemarroy A; Troyo-Sanroman R; Bravo-Cuellar A; Delgado-Rizo V; Garcia-Iglesias T; Hernandez-Flores G; Del Toro-Arreola S
    BMC Cancer; 2008 Jan; 8():16. PubMed ID: 18208618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer group 2 member D cell recruitment driven by major histocompatibility complex class I chain-related antigens A and B: a possible mechanism during acute intestinal allograft rejection in the mouse.
    Joshi M; Dindelegan G; Olausson M; Oltean M
    Transplant Proc; 2010 Dec; 42(10):4467-9. PubMed ID: 21168719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
    Rebmann V; Schütt P; Brandhorst D; Opalka B; Moritz T; Nowrousian MR; Grosse-Wilde H
    Clin Immunol; 2007 Apr; 123(1):114-20. PubMed ID: 17218152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MICA expression, anti-MICA antibodies and serum MICA during acute rejection in a rat-to-mouse cardiac transplantation model.
    Yu R; Xu S; Wang Y; Cai H; Xu P
    Int J Clin Exp Pathol; 2015; 8(11):14514-20. PubMed ID: 26823771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Major Histocompatibility Complex Class I related Chain A (sMICA) levels influence graft outcome following Renal Transplantation.
    Baranwal AK; Goswami S; Bhat DK; Kaur G; Agarwal SK; Mehra NK
    Hum Immunol; 2018 Mar; 79(3):160-165. PubMed ID: 29330111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.